Dear Reader,
You already know the story. Everyone does.
The weight-loss drugs took over the headlines, the drugmakers behind them became two of the most valuable companies on Earth, and most investors figured the trade was over.
It isn't. It's barely started.
Because a boom this size doesn't stop at two companies. It needs manufacturers. Ingredient suppliers. Delivery devices. Telehealth platforms writing the prescriptions. An entire supply chain most investors have never looked at.
Our research desk mapped that supply chain and found ten publicly traded companies positioned to benefit as this market grows.
The GLP-1 Gold Rush: 10 Stocks Riding the Weight-Loss Drug Boom names all ten, with tickers and the thesis for each.
The report is free today.
Claim My Free Copy of the GLP-1 Report
By clicking this link you agree to receive emails from us and our affiliates. You can opt out at any time. Privacy Policy.
— Edward Strauss
Editor, Financial Edge Daily
P.S. Everyone knows the two obvious names. The other ten are where the opportunity still lives. Get the free list now.
No comments:
Post a Comment